Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica

Abstract

Background:

In contrast to multiple sclerosis (MS), lesions in neuromyelitis optica (NMO) frequently contain neutrophils. However, the phenotypic profile of neutrophils in these two distinct pathologies remains unknown.

Objective:

Our aim is to better understand the potential contribution of neutrophils to NMO and MS pathology.

Methods:

We performed the first functional analysis of blood neutrophils in NMO and MS, including evaluation of neutrophil immune response (fMLP receptor, TLR2), chemotaxis and migration (CXCR1, CD62L, CD43), regulation of complement (CD46, CD55, CD59), respiratory burst, phagocytosis and degranulation.

Results:

Compared with healthy controls (HC), neutrophils in NMO and MS show an activated phenotype characterized by an increased surface expression of TLR2 and fMLP receptor. However, contrary to MS neutrophils, NMO neutrophils show reduced adhesion and migratory capacity as well as decreased reduced production of reactive oxygen species (respiratory burst) and degranulation.

Conclusion:

Although NMO and MS neutrophils display an activated phenotype in comparison with HC, NMO neutrophils show a compromised functionality when compared with MS patients. These results suggest a distinct functional profile of neutrophils in MS and NMO.

Keywords

Neutrophils innate immunity multiple sclerosis neuromyelitis optica

Get full access to this article

View all access options for this article.

References

Sospedra

Martin

. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683–747.

Jarius

Wildemann

Paul

. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Experimental Immunol 2014; 176: 149–164.

Pfueller

Paul

. Imaging the visual pathway in neuromyelitis optica. Mult Scler Int 2011; 2011: 869814.

Lennon

Wingerchuk

Kryzer

. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112.

Jarius

Ruprecht

Wildemann

. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflamm 2012; 9: 14.

Amulic

Cazalet

Hayes

. Neutrophil function: From mechanisms to disease. Annu Rev Immunol 2012; 30: 459–489.

Lucchinetti

Mandler

McGavern

. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002; 125: 1450–1461.

Saadoun

Waters

MacDonald

. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol 2012; 71: 323–333.

Wingerchuk

Lennon

Pittock

. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485–1489.

10.

Polman

Reingold

Banwell

. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

11.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444–1452.

12.

Roberts

. G-CSF: A key regulator of neutrophil production, but that’s not all! Growth Factors 2005; 23: 33–41.

13.

Camous

Roumenina

Bigot

. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 2011; 117: 1340–1349.

14.

Futosi

Fodor

Mocsai

. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol 2013; 17: 1185–1197.

15.

Naegele

Tillack

Reinhardt

. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol 2012; 242: 60–71.

16.

Matsumoto

Shigeta

Miyasaka

. CD43 plays both antiadhesive and proadhesive roles in neutrophil rolling in a context-dependent manner. J Immunol 2008; 181: 3628–3635.

17.

Hayashi

Means

Luster

. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102: 2660–2669.

18.

Videm

Strand

. Changes in neutrophil surface-receptor expression after stimulation with FMLP, endotoxin, interleukin-8 and activated complement compared to degranulation. Scand J Immunol 2004; 59: 25–33.

19.

Meddows-Taylor

Kuhn

Meyers

. Altered expression of L-selectin (CD62L) on polymorphonuclear neutrophils of children vertically infected with human immunodeficiency virus type 1. J Clin Immunol 2001; 21: 286–292.

20.

Bruck

Popescu

Lucchinetti

. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol 2012; 72: 385–394.

21.

Misu

Hoftberger

Fujihara

. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013; 125: 815–827.

22.

Ingram

Hakobyan

Robertson

. Complement in multiple sclerosis: Its role in disease and potential as a biomarker. Clin Exp Immunol 2009; 155: 128–139.

23.

Ostberg

Barth

Frelinger

. The Roman god Janus: A paradigm for the function of CD43. Immunol Today 1998; 19: 546–550.

24.

Zarbock

Ley

McEver

. Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood 2011; 118: 6743–6751.

25.

Tavares-Murta

Zaparoli

Ferreira

. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 2002; 30: 1056–1061.

26.

Alves-Filho

Freitas

Souto

. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci U S A 2009; 106: 4018–4023.

27.

Pletz

Ioanas

de Roux

. Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J 2004; 23: 532–537.

28.

Harter

Mica

Stocker

. MCL-1 correlates with reduced apoptosis in neutrophils from patients with sepsis. J Am Coll Surg 2003; 197: 964–973.